Skip to main content

Peripheral Arterial Diseases

3
Pipeline Programs
7
Companies
7
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Boston Scientific
Boston ScientificCA - Valencia
2 programs
1
Jetstream Atherectomy SystemPhase 41 trial
EPIC™ Self-Expanding Nitinol Vascular StentN/A1 trial
Active Trials
NCT01336101Completed100Est. Nov 2012
NCT01436435Completed241Est. Feb 2016
AngioDynamics
AngioDynamicsChina - Hong Kong
1 program
1
Auryon Atherectomy SystemPhase 41 trial
Active Trials
NCT06777901Recruiting224Est. Apr 2029
Mercator MedSystems
Mercator MedSystemsCA - San Leandro
1 program
1
Dexamethasone Sodium Phosphate Injection, USPPhase 41 trial
Active Trials
NCT01983449Completed285Est. Jan 2018
Medtronic
MedtronicNJ - Phillipsburg
1 program
EverFlex™ stent with Entrust™ delivery systemN/A1 trial
Active Trials
NCT02066740Completed34Est. Jul 2014
Lee's Pharmaceutical
Lee's PharmaceuticalChina - Guangzhou
1 program
Propionyl-L-Carnitine HydrochloridePHASE_11 trial
Active Trials
NCT02786043Completed12Est. Jan 2016
Cordis
CordisFL - Miami Lakes
1 program
balloon angioplastyPHASE_41 trial
Active Trials
NCT00640770Completed200Est. Jan 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
AngioDynamicsAuryon Atherectomy System
Mercator MedSystemsDexamethasone Sodium Phosphate Injection, USP
Boston ScientificJetstream Atherectomy System
Cordisballoon angioplasty
Lee's PharmaceuticalPropionyl-L-Carnitine Hydrochloride
MedtronicEverFlex™ stent with Entrust™ delivery system
Boston ScientificEPIC™ Self-Expanding Nitinol Vascular Stent

Clinical Trials (7)

Total enrollment: 1,096 patients across 7 trials

NCT06777901AngioDynamicsAuryon Atherectomy System

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

Start: Apr 2025Est. completion: Apr 2029224 patients
Phase 4Recruiting
NCT01983449Mercator MedSystemsDexamethasone Sodium Phosphate Injection, USP

Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease

Start: Nov 2013Est. completion: Jan 2018285 patients
Phase 4Completed
NCT01436435Boston ScientificJetstream Atherectomy System

The Jetstream (JET) Post-market Registry

Start: Sep 2011Est. completion: Feb 2016241 patients
Phase 4Completed
NCT00640770Cordisballoon angioplasty

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease

Start: Mar 2008Est. completion: Jan 2011200 patients
Phase 4Completed
NCT02786043Lee's PharmaceuticalPropionyl-L-Carnitine Hydrochloride

PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses

Start: Jun 2015Est. completion: Jan 201612 patients
Phase 1Completed
NCT02066740MedtronicEverFlex™ stent with Entrust™ delivery system

EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study

Start: Feb 2014Est. completion: Jul 201434 patients
N/ACompleted
NCT01336101Boston ScientificEPIC™ Self-Expanding Nitinol Vascular Stent

Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent

Start: Apr 2011Est. completion: Nov 2012100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,096 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.